Angel News
Angel News
Angel News

Back to Homepage

7th March 2018

Cellesce closes fundraising to grow cancer organoid business

Cellesce the cancer organoid bioprocessing and scale-up company has announced a successful six-figure funding round that will open up opportunities to introduce its organoid scale-up and expansion technology to the oncology drug discovery screening market. This funding round has, once again, been led by the Development Bank of Wales, a measure of the confidence it has in both the Cellesce technology and the founding team.

...

Register now to read full story

In order to read the full story we need you to register with us, please click the link below:

Register Now

Add a comment:

Name:

Email:

Comment:

Enter the characters in the image shown:



Back to Homepage